Cord Blood
Cord Blood
Cord Blood
together
Preserving your newborn’s stem cells can help you prepare for your child’s future. We’ve gathered a few
common questions about newborn stem cells and CBR in hopes that you will find them useful as you
learn about your options.
What is the difference between preserving newborn stem cells for your family
CBR
and donating?
Family: Set up in advance of delivery, this process preserves your baby’s cord blood and/or
cord tissue for potential future use by your family. Should it be needed in the future, this
financial investment provides you access to a unique resource that may open doors to
future stem cell treatments for your family.
• CBR believes that every family should have the opportunity to preserve their baby’s newborn
stem cells. That’s why we created several affordable payment options that fit almost every
family’s budget
• CBR’s Newborn Possibilities Program® helps families with a qualifying medical need preserve their
child’s newborn stem cells by covering all costs for processing and 5 years of storage
Comprehensive Support:
• CBR’s Certified Genetic Counselors are available to speak with your family about newborn stem
cells options and to provide education about stem cell research. Our counselors can discuss your
family’s medical history and how newborn stem cells may be applicable to you
• CBR’s Family Health Registry™ helps to identify conditions that are common among CBR families.
That way, we can partner with researchers to study conditions that are important to our families and
connect them to clinical trials
Unparalleled Commitment:
• CBR constantly invests in our laboratory and storage facility to help protect your family’s
precious resource
• CBR’s mission is to help advance the science of newborn stem cells. Our partnerships with
reputable research institutions on FDA-regulated clinical trials that focus on stem cell research
are helping us achieve that mission
Ultimate use of newborn stem cells will be determined by the treating physician, who will consider if they are applicable for the
condition and should come from the patient or a suitable donor (siblings of the same biological parents have a 25% chance of being
a perfect match and a 50% chance of being a partial match; biological parents will always be a partial match). There is no guarantee
that treatments being studied in the laboratory, clinical trials, or other experimental treatments (including regenerative medicine
applications) will be available in the future.
Cord tissue use is still in early research stages, and there is no guarantee that treatments using cord tissue will be available in the
future. Should such use become available, cord tissue will require additional processing prior to use. CBR is currently evaluating the
potential to isolate and prepare multiple cell types from cryopreserved cord tissue for potential future use.
Cbr Systems, Inc.’s activities for New York State residents are limited to collection of umbilical cord tissue and long-term storage of
umbilical cord–derived stem cells. Cbr Systems, Inc.’s possession of a New York State license for such collection and long-term
storage does not indicate approval or endorsement of possible future uses or future suitability of these cells.